ElleVet Sciences Promotes Haley Israelson to Chief Executive Officer

ElleVet Sciences has promoted Haley Israelson to Chief Executive Officer.

Israelson, ElleVet’s current Chief Financial Officer, will assume the role of CEO on Jan. 1, 2025. Having joined ElleVet as Head of Finance in 2019, Israelson has been instrumental in fueling and managing the exponential growth of the company. In her tenure at ElleVet Sciences, Israelson has managed many functions in addition to Finance, including e-Commerce and Operations (production, order fulfillment and supply chain).

“I am honored to become the CEO of ElleVet Sciences, an amazing company and a pioneer in the field of science-backed nutraceuticals for pets. Central to ElleVet’s DNA is our science first approach, our promise to provide outstanding customer experiences, and our commitment to always doing what is right. These core elements provide an impactful framework for all decision making and I look forward to continuing to live by and lead with these company values,” said Israelson.

“ElleVet Sciences’ Board of Directors has conducted a year-long search for our next CEO to help develop ElleVet to its full potential. We could not be more pleased with this outcome. Haley has a deep understanding of all aspects of the business and is a highly valued member of our team. ElleVet has invested significantly in scientific research with more than 40 clinical studies and R&D projects completed or underway, including recent advancements in feline and equine health that we look forward to sharing in early 2025. I see no better candidate than Haley to execute on the amazing opportunities on the horizon and I look forward to continuing to support the company as a member of the Board,” said Christian Kjaer, ElleVet Sciences Co-founder, Chair and CEO.